NCT06770569
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06770569
Title Safety, Tolerability, and Pharmacokinetics of HRS-3802 Monotherapy in Patients With Malignant Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Shandong Suncadia Medicine Co., Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
GenesisCare North Shore (Oncology) ACTIVE_NOT_RECRUITING Saint Leonards New South Wales 2065 Australia Details
Macquarie University Hospital ACTIVE_NOT_RECRUITING Sydney New South Wales 2109 Australia Details
John Flynn Private Hospital ACTIVE_NOT_RECRUITING Tugun Queensland 4224 Australia Details
GenesisCare St Andrews ACTIVE_NOT_RECRUITING Adelaide South Australia 5000 Australia Details
Peninsula and South Eastern Haematology & Oncology Group ACTIVE_NOT_RECRUITING Frankston Victoria 3199 Australia Details
Cancer Hospital Chinese Academy of Medical Sciences RECRUITING Beijing Beijing Municipality 100021 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field